Items where Author is "Bruemmendorf, T. H."

Bruemmendorf, T. H. ; Cervantes, F. ; Kim, D. ; Chandy, M. ; Fischer, T. ; Hochhaus, A. ; Liu, D. ; Ossenkoppele, G. J. ; Hewes, B. ; Cortes, J. E. (2008) Bosutinib is safe and active in patients (pts) with chronic phase (CP) chronic myeloid leukemia (CML) with resistance or intolerance to imatinib and other tyrosine kinase inhibitors Journal of Clinical Oncology, 26 (15S). No pp. given. ISSN 0732-183X